Quest Partners LLC Buys New Shares in UnitedHealth Group Incorporated (NYSE:UNH)

Quest Partners LLC bought a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund bought 1,269 shares of the healthcare conglomerate’s stock, valued at approximately $668,000.

Several other institutional investors have also recently bought and sold shares of the business. Texas Capital Bancshares Inc TX lifted its stake in shares of UnitedHealth Group by 1.1% in the 3rd quarter. Texas Capital Bancshares Inc TX now owns 1,695 shares of the healthcare conglomerate’s stock valued at $855,000 after purchasing an additional 19 shares during the last quarter. Tealwood Asset Management Inc. lifted its stake in shares of UnitedHealth Group by 0.4% in the 4th quarter. Tealwood Asset Management Inc. now owns 4,988 shares of the healthcare conglomerate’s stock valued at $2,626,000 after purchasing an additional 19 shares during the last quarter. Atlas Private Wealth Advisors lifted its stake in shares of UnitedHealth Group by 1.1% in the 4th quarter. Atlas Private Wealth Advisors now owns 1,752 shares of the healthcare conglomerate’s stock valued at $923,000 after purchasing an additional 19 shares during the last quarter. Prentice Wealth Management LLC lifted its stake in shares of UnitedHealth Group by 0.8% in the 4th quarter. Prentice Wealth Management LLC now owns 2,347 shares of the healthcare conglomerate’s stock valued at $1,235,000 after purchasing an additional 19 shares during the last quarter. Finally, Baker Avenue Asset Management LP lifted its stake in UnitedHealth Group by 1.7% during the 3rd quarter. Baker Avenue Asset Management LP now owns 1,219 shares of the healthcare conglomerate’s stock worth $615,000 after acquiring an additional 20 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

NYSE UNH opened at $521.41 on Thursday. The stock has a market cap of $479.90 billion, a price-to-earnings ratio of 31.87, a price-to-earnings-growth ratio of 1.52 and a beta of 0.55. The business has a fifty day moving average of $488.32 and a 200-day moving average of $511.06. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $554.70. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.69.

UnitedHealth Group (NYSE:UNHGet Free Report) last issued its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The business had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. During the same period in the previous year, the firm posted $6.26 earnings per share. The company’s quarterly revenue was up 8.6% compared to the same quarter last year. As a group, analysts predict that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were given a dividend of $1.88 per share. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 annualized dividend and a yield of 1.44%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 45.97%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on UNH shares. Royal Bank of Canada reduced their price target on UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 17th. Wells Fargo & Company reduced their price target on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating on the stock in a research report on Monday, April 8th. Bank of America reaffirmed a “buy” rating and issued a $675.00 price target on shares of UnitedHealth Group in a research report on Thursday, March 7th. Truist Financial reiterated a “buy” rating and issued a $600.00 price objective on shares of UnitedHealth Group in a report on Wednesday, April 17th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and issued a $591.00 price objective on shares of UnitedHealth Group in a report on Wednesday, April 10th. Three equities research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $570.05.

Check Out Our Latest Stock Report on UNH

Insider Activity

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In related news, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares in the company, valued at approximately $4,527,306.72. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the sale, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The disclosure for this sale can be found here. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Articles

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.